Angiotensin II type 1 receptor and the activation of Myosin Light-Chain Kinase and Protein Kinase C-βII: Mini Review
Article Sidebar
Main Article Content
Abstract
The involvement of the angiotensin II type 1 receptor in the Frank-Starling Law of the Heart, where the various activations are very limited, allows simple analysis of the kinase systems involved and thence extrapolation of the mechanism to that of angiotensin control of activation of cardiac and skeletal muscle contraction. The involvement of phosphorylation of the myosin light chain in the control of contraction is accepted but not fully understood. The involvement of troponin-I phosphorylation is also indicated but of unknown mechanism. There is no known signal for activation of myosin light chain kinase or Protein Kinase C-βII other than Ca2+/calmodulin but the former is constitutively active and thus has to be under control of a regulated inhibitor, the latter kinase may also be the same. Ca2+/calmodulin is not activated in Frank-Starling, i.e. there are no diastolic or systolic [Ca2+] changes. I suggest here that the regulated inhibition is by myosin light chain phosphatase and/or β-arrestin. Angiotensin activation, not involving G proteins. is by translocation of the β-arrestin from the sarcoplasm to the plasma membrane thus reducing its kinase inhibition action in the sarcoplasm. This reduced inhibition has been wrongly attributed to a mythical downstream agonist property of β-arrestin.
Article Details
Copyright (c) 2020 Smith GA.
This work is licensed under a Creative Commons Attribution 4.0 International License.
van der Velden J, de Jong JW, Owen VJ, Burton PB, Stienen GJ, Effect of protein kinase A on calcium sensitivity of force and its sarcomere length dependence in human cardiomyocytes. Cardiovasc Res. 2000; 46: 487–495. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10912459 DOI: https://doi.org/10.1016/S0008-6363(00)00050-X
Steinberg SF. Cardiac actions of protein kinase C isoforms. Physiology. 2012; 27: 130–139. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22689788 DOI: https://doi.org/10.1152/physiol.00009.2012
Chandra M, Dong WJ, Pan BS, Cheung HC, Solaro RJ. Effects of Protein Kinase A Phosphorylation on Signaling between CardiacTroponin I and the N-Terminal Domain of Cardiac Troponin C. Biochemistry; 1997; 36: 13305-13311. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9341222 DOI: https://doi.org/10.1021/bi9710129
Kobayashi T, Dong WJ, Burkart EM, Cheung HC, Solaro RJ. Effects of Protein Kinase C Dependent Phosphorylation and a Familial Hypertrophic Cardiomyopathy-Related Mutation of Cardiac Troponin I on Structural Transition of Troponin C and Myofilament Activation. Biochemistry. 2004; 43: 5996-6004. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15147183 DOI: https://doi.org/10.1021/bi036073n
Smith GA. The Mechanisms of the Frank-Starling Law and Familial Cardiomyopathy are Different. The Function of Myosin Binding Protein-C is Retained on Myocyte Length Increase and Force Generated is Kinase controlled. OAT J Integr Cardiol. 2019; 5. DOI: https://doi.org/10.20944/preprints201910.0068.v1
Smith GA. Calcium, Actomyosin Kinetics, Myosin Binding Protein-C and Hypertrophic Cardiomyopathy. OAT J Integr Cardiol. 2019; 5. DOI: https://doi.org/10.20944/preprints201910.0067.v1
Solaro RJ, Shiner JS. Modulation of Ca2+ control of dog and rabbit cardiac myofibrils by Mg2+. Comparison with rabbit skeletal myofibrils. Circ Res. 1972; 39: 8–14. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/132310 DOI: https://doi.org/10.1161/01.RES.39.1.8
Lionne C1, Brune M, Webb MR, Travers F, Barman T. Time resolved measurements show that phosphate release is the rate limiting step on myofibrillar ATPases. FEBS Letters. 1995; 364: 59-62. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7750544 DOI: https://doi.org/10.1016/0014-5793(95)00356-E
Lymn RW, Taylor EW. Transient state phosphate production in the hydrolysis of nucleoside triphosphates by myosin. Biochemistry. 1970; 9: 2975–2983. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/4248809 DOI: https://doi.org/10.1021/bi00817a007
Pan BS, Solaro RJ. Calcium-binding properties of troponin-C in detergent skinned heart muscle fibers. J Biol Chem. 1987; 262: 7839-7849. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3584144 DOI: https://doi.org/10.1016/S0021-9258(18)47644-2
Morimoto S, Ohtsuki I. Ca2+ binding to cardiac troponin-C in the myofilament lattice and its relation to myofibrillar ATPase activity. Eur J Biochem. 1994; 226: 597-602. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8001574 DOI: https://doi.org/10.1111/j.1432-1033.1994.tb20085.x
Kampourakis T, Yan Z, Gautel M, Sun YB, Irving M. Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells. Proc Natl Acad Sci U S A. 2014; 111: 18763–18768. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25512492 DOI: https://doi.org/10.1073/pnas.1413922112
Hofmann PA, Hartzell HC, Moss RL. Alterations in Ca2+ sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol. 1991; 97: 1141–1463. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1678777 DOI: https://doi.org/10.1085/jgp.97.6.1141
Zhang X, Kampourakis T, Yan Z, Sevrieva I, Irving M. et al. Distinct contributions of the thin and thick filaments to length-dependent activation in heart muscle. eLife. 2017; 6: e24081. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28229860 DOI: https://doi.org/10.7554/eLife.24081
de Tombe PP, Mateja RD, Tachampa K, Ait Mou Y, Farman GP, et al. Myofilament length dependent activation. J Mol Cell Cardiol. 2010; 48: 851–858. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20053351 DOI: https://doi.org/10.1016/j.yjmcc.2009.12.017
Akella AB, Su H, Sonnenblick EH, Rao VG, Gulati J. The Cardiac Troponin C Isoform and the Length Dependence of Ca2+ Sensitivity of Tension in Myocardium. J Mol Cell Cardiol. 1997; 29: 381–389. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9040052 DOI: https://doi.org/10.1006/jmcc.1996.0282
Tachampa K, Wang H, Farman GP, de Tombe PP. Cardiac Troponin I Threonine 144. Role in Myofilament Length–Dependent Activation. Circ Res. 2007; 101: 1081-1083. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17975107 DOI: https://doi.org/10.1161/CIRCRESAHA.107.165258
Wang H, Grant JE, Doede CM, Sadayappan S, Robbins J, et al. PKC-βII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. J Mol Cell Cardiol. 2006; 41: 823-833. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17010989 DOI: https://doi.org/10.1016/j.yjmcc.2006.08.016
Blobe GC, Stribling DS, Fabbro D, Stabel S, Hannun YA. Protein Kinase C-βII specifically binds to and is activated by F-actin. J Biol Chem. 1996; 271: 26: 15823–15830. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8663149 DOI: https://doi.org/10.1074/jbc.271.26.15823
Abraham DM, Davis RT, Warren CM, Mao L, Wolska BM. et al. β-Arrestin mediates the Frank–Starling mechanism of cardiac contractility. Proc Natl Acad Sci U S A. 2016; 113: 50: 14426–14431. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27911784 DOI: https://doi.org/10.1073/pnas.1609308113
Ponnam S, Sevrieva I, Sun YB, Irving M, Kampourakis T. Site-specific phosphorylation of myosin binding protein-C coordinates thin and thick filament activation in cardiac muscle. PNAS. 2019; 116: 15485-15494. DOI: https://doi.org/10.1073/pnas.1903033116
Ribas C, Penela P, Murga C, Salcedo A, García-Hoz C, et al. The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling. Biochimica et Biophysica Acta (BBA) – Biomembranes. 2007; 1768: 913-922. DOI: https://doi.org/10.1016/j.bbamem.2006.09.019
Gurevich VV, Gurevich EV. GPCR Signaling Regulation: The Role of GRKs and Arrestins. Frontiers in Pharmacology. 2019; 10: 125. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389790/ DOI: https://doi.org/10.3389/fphar.2019.00125
Wolf H, Hofmann F. Purification of myosin light chain kinase from bovine cardiac muscle. Proc Natl Acad Sci U S A. 1980; 77: 5852-5855. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/6934518 DOI: https://doi.org/10.1073/pnas.77.10.5852
Walsh MP, Vallet B, Autric F, Demaille JG. Purification and Characterization of Bovine Cardiac Calmodulin dependent Myosin Light Chain Kinase. J Biol Chem. 1979; 254: 12136-12144. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/500701 DOI: https://doi.org/10.1016/S0021-9258(19)86440-2
Wilden U, Hall SW, Kühn H. Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci U S A. 1986; 83: 1174–1178. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3006038 DOI: https://doi.org/10.1073/pnas.83.5.1174
Wilden U, Wüst E, Weyand I, Kühn H. Rapid affinity purification of retinal arrestin (48 kDa protein) via its light-dependent binding to phosphorylated rhodopsin. FEBS Lett. 1986; 207: 292–295. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/3770202 DOI: https://doi.org/10.1016/0014-5793(86)81507-1
Turu G, Balla A, Hunyady L. The Role of b-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor. Front Endocrinol (Lausanne). 2019; 10: 519. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31447777 DOI: https://doi.org/10.3389/fendo.2019.00519
Gagnon L, Yubo Cao Y, Cho A, Sedki D, Huber T, et al. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor. J Biol Chem. 2019; 294; 17409-17420. DOI: https://doi.org/10.1074/jbc.RA119.010324
Ishikawa Y, Kurotani R. Cardiac Myosin Light Chain Kinase, A New Player in the Regulation of Myosin Light Chain in the Heart. Circ Res. 2008; 102: 516-518. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18340016 DOI: https://doi.org/10.1161/CIRCRESAHA.108.173005
Stelzer JE, Patel JR, Moss RL. Acceleration of stretch activation in murine myocardium due to phosphorylation of myosin regulatory light chain. J Gen Physiol. 2006; 128: 261–272. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16908724 DOI: https://doi.org/10.1085/jgp.200609547
Chang AN, Kamm KE, Stull JT. Role of myosin light chain phosphatase in cardiac physiology and pathophysiology. J Mol Cell Cardiol. 2016; 101: 35–43. PubMed: DOI: https://doi.org/10.1016/j.yjmcc.2016.10.004
Kumar M, Govindan S, Zhang M, Khairallah RJ, Martin JL, et al. Cardiac myosin-binding protein C and troponin-I phosphorylation independently modulate myofilament length-dependent activation. J Biol Chem. 2015; 290: 29241–29249. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26453301 DOI: https://doi.org/10.1074/jbc.M115.686790
Mamidi R, Gresham KS, Verma S, Stelzer JE. Cardiac Myosin Binding Protein-C Phosphorylation Modulates Myofilament Length-Dependent Activation. Front Physiol. 2016; 7: Article 38. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753332/ DOI: https://doi.org/10.3389/fphys.2016.00038
Sheikh F, Lyon RC, Chen J. Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease. Gene. 2015; 569: 14–20. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26074085 DOI: https://doi.org/10.1016/j.gene.2015.06.027
Ding P, Huang J, Battiprolu PK, Hill JA, Kamm KE, et al. Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performance in Vivo. J Biol Chem. 2010; 285: 40819-40829. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003383/ DOI: https://doi.org/10.1074/jbc.M110.160499